B. Mitlak
Impact in
-
- Bone health and osteoporosis research
- Bone and Joint Diseases
-
- Bone health and treatments
Papers in
-
- Bone health and osteoporosis research 6
- Bone and Joint Diseases 1
-
- Bone Metabolism and Diseases 3
- Co-authors
- Jean‐Marc Kaufman (1 shared paper)Robert S. Lindsay (1 shared paper)Javier San Martín (1 shared paper)Stefan Goemaere (1 shared paper)Anwar Hossain (1 shared paper)G. P. Dalsky (1 shared paper)Eric Orwoll (1 shared paper)Harry K. Genant (1 shared paper)
- Journals
- Osteoporosis International (2 papers)Current Opinion in Pharmacology (1 paper)Open Repository and Bibliography (University of Liège) (3 papers)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
B. Mitlak
6 papers receiving 325 citations
Peers
Comparison fields: 5 of 42
- Orthopedics and Sports Medicine 293
- Oncology 191
- Nephrology 26
- Pathology and Forensic Medicine 42
- Surgery 88
Countries citing papers authored by B. Mitlak
This map shows the geographic impact of B. Mitlak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Mitlak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Mitlak more than expected).
Fields of papers citing papers by B. Mitlak
This network shows the impact of papers produced by B. Mitlak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Mitlak. The network helps show where B. Mitlak may publish in the future.
Co-authors
The 25 scholars most cited alongside B. Mitlak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 222 | |
| 2 | 2008 | 76 | |
| 3 | The effect of 2 and 3 years of Raloxifene on vertebral and non-vertebral fractures in postmenopausal women with osteoporosis | 1998 | 17 |
| 4 | 2002 | 16 | |
| 5 | Effects of arzoxifene on fracture incidence in postmenopausal women with osteoporosis or with low bone mass | 2010 | 2 |
| 6 | Raloxifene therapy for 3 years reduces the risk of incident vertebral fractures in postmenopausal women | 1999 | 2 |
About B. Mitlak
B. Mitlak is a scholar working on Orthopedics and Sports Medicine, Molecular Biology, Oncology, Genetics and Surgery, having authored 6 papers that have together received 335 indexed citations. Recurring topics across this work include Bone health and osteoporosis research (6 papers), Bone health and treatments (3 papers), Estrogen and related hormone effects (3 papers), Bone Metabolism and Diseases (3 papers), Pelvic and Acetabular Injuries (1 paper), Medical Imaging and Analysis (1 paper) and Bone and Joint Diseases (1 paper). The work is most often cited by research in Orthopedics and Sports Medicine (293 citations), Oncology (191 citations), Nephrology (26 citations), Pathology and Forensic Medicine (42 citations) and Surgery (88 citations). B. Mitlak has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Jean‐Marc Kaufman, Robert S. Lindsay, Javier San Martín, Stefan Goemaere, Anwar Hossain, G. P. Dalsky, Eric Orwoll, Harry K. Genant, Michael J. Econs and Thomas Fuerst. Their work appears in journals such as Osteoporosis International, Current Opinion in Pharmacology and Open Repository and Bibliography (University of Liège).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.